Voloridge Investment Management
CRL icon

Voloridge Investment Management’s Charles River Laboratories CRL Stock Holding History

Voloridge Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-87,227
Closed -$13.6M – 1180
2025
Q3 		$13.6M Sell
87,227
-4,584
-5% -$728K 0.05% 453
2025
Q2 		$13.9M Sell
91,811
-44,924
-33% -$5.99M 0.05% 440
2025
Q1 		$20.6M Sell
136,735
-19,839
-13% -$3.33M 0.08% 350
2024
Q4 		$28.9M Buy
156,574
+80,918
+107% +$15.6M 0.1% 260
2024
Q3 		$14.9M Buy
75,656
+68,458
+951% +$14.2M 0.05% 459
2024
Q2 		$1.49M Buy
+7,198
New +$1.63M 0.01% 993
2023
Q3 		– Sell
-49,688
Closed -$10.4M – 1413
2023
Q2 		$10.4M Buy
+49,688
New +$9.89M 0.05% 454
2022
Q4 		– Sell
-217,836
Closed -$42.9M – 1467
2022
Q3 		$42.9M Sell
217,836
-37,674
-15% -$8.13M 0.23% 119
2022
Q2 		$54.7M Buy
255,510
+118,618
+87% +$29M 0.28% 91
2022
Q1 		$38.9M Buy
136,892
+80,856
+144% +$24.9M 0.22% 117
2021
Q4 		$21.1M Buy
56,036
+55,116
+5,991% +$21.4M 0.12% 248
2021
Q3 		$380K Buy
+920
New +$382K ﹤0.01% 1503
2020
Q3 		– Sell
-14,660
Closed -$2.56M – 1285
2020
Q2 		$2.56M Buy
+14,660
New +$2.34M 0.03% 535
2020
Q1 		– Sell
-27,727
Closed -$4.24M – 1137
2019
Q4 		$4.24M Buy
+27,727
New +$3.84M 0.08% 315
2019
Q2 		– Sell
-5,044
Closed -$733K – 800
2019
Q1 		$733K Buy
+5,044
New +$663K 0.02% 569
2017
Q4 		– Sell
-8,190
Closed -$885K – 496
2017
Q3 		$885K Buy
+8,190
New +$841K 0.02% 332
2016
Q2 		– Sell
-8,114
Closed -$616K – 322
2016
Q1 		$616K Buy
+8,114
New +$601K 0.01% 267
2015
Q2 		– Sell
-22,525
Closed -$1.79M – 318
2015
Q1 		$1.79M Buy
+22,525
New +$1.66M 0.09% 191

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Voloridge Investment Management's CRL Position: Q4 2025 in Review

Voloridge Investment Management sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 87,227 shares — an estimated $13.6M sold.

Voloridge Investment Management first reported a position in CRL in Q1 2015 and held it in 18 quarters. The position peaked at $54.7M in Q2 2022. 580 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • Voloridge Investment Management reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 87,227 Charles River Laboratories shares in Q4 2025, an estimated $13.6M.
  • Voloridge Investment Management first reported a position in Charles River Laboratories in Q1 2015 and held it in 18 quarters.
  • Voloridge Investment Management's Charles River Laboratories position peaked at $54.7M in Q2 2022.
  • 580 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Voloridge Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.